Anti-bladder cancer and COVID-19 potentials of pachymic acid: clinical features and therapeutic targets-Reference-Cited by-同舟云学术

Anti-bladder cancer and COVID-19 potentials of pachymic acid: clinical features and therapeutic targets

Published:2023-09-05 Issue:1 Volume:26 Page:2679-2691
ISSN:1094-2912
Container-title:International Journal of Food Properties
language:en
Short-container-title:International Journal of Food Properties

Author:

Zhou Baotong¹²,Liang Bojian³⁴,Chen Min³⁴,Tang Yongbo³⁴,Hu Haiwei³⁴,Chen Qiuhong³⁴,Wen Jintao³⁴,Wen Zhouliang³⁴,Cui Ende³⁴,Zhong Wei³⁴,Su Jimin³⁴,Ge Bo³⁵

Affiliation:

1. Department of Urology Surgery, The Affiliated Hospital of Guilin Medical University, Guilin, PR China

2. Department of Nephrology, University of Duisburg-Essen, Germany

3. Department of Urology Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin, PR China

4. Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin, China

5. Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Food Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/10942912.2023.2252194

Reference46 articles.

1. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

2. Vaccination to Reduce Severe COVID-19 and Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis;Huang Y. Z.;Eu.R Rev. Med. Pharmacol. Sci,2022

3. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

4. Cancer Research Ethics and COVID-19

5. Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy